PD-L1 Expression (TPS >= 50%) | Cancer Search

Details 0 Trials 3 Therapies

mutation class

mutation class

Gene Expression

Show 0 Trials for PD-L1 Expression (TPS >= 50%)

cemiplimab

biomarker

PD-L1 Expression (TPS >= 50%)

condition

Non-Small Cell Lung Carcinoma

disease state

Locally advanced, +1 more state

therapeutic contexts

First line

drug

cemiplimab

drug type

immunotherapy

cemiplimab

biomarker

PD-L1 Expression (TPS >= 50%)

condition

Non-Small Cell Lung Carcinoma

disease state

Advanced, +1 more state

therapeutic contexts

First line

drug

cemiplimab

drug type

immunotherapy

pembrolizumab

biomarker

PD-L1 Expression (TPS >= 50%)

condition

Non-Small Cell Lung Carcinoma

disease state

Advanced, +1 more state

therapeutic contexts

First line

drug

pembrolizumab

drug type

immunotherapy

Show 3 Therapies for PD-L1 Expression (TPS >= 50%)